Therapeutic potential of CD8+ cytotoxic T lymphocytes in SLE

Autoimmunity Reviews

Volumn 8, Issue 3, 2009, Pages 219-223

  Puliaeva, I ^a   Puliaev, R ^a   Via, C S ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Cytotoxic T cells; Graft vs host disease; Lupus

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; FAS LIGAND; INTERLEUKIN 12; POLYCLONAL ANTIBODY;

AUTOIMMUNITY; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL TRANSFER; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; GRAFT VERSUS HOST REACTION; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PHENOTYPE; POLYCLONAL ACTIVATION; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; B-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HOMEOSTASIS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, CONGENIC; T-LYMPHOCYTES, CYTOTOXIC;

EID: 60149100987     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2008.07.045     Document Type: Review

References (40)

1. Mohan C., Adams S., Stanik V., and Datta S.K. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 177 (1993) 1367-1381
2. Horwitz D.A., Stohl W., and Gray J.D. T lymphocytes, natural killer cells and immune regulation. In: Wallace D.J., and Hahn B.H. (Eds). Dubois' Lupus Erythematosus (2002), Lippincott Williams & Wilkins, Philadelphia 157-185
3. Mevorach D., Zhou J.L., Song X., and Elkon K.B. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 188 (1998) 387-392
4. Singh R.R., Ebling F.M., Albuquerque D.A., Saxena V., Kumar V., Giannini E.H., et al. Induction of autoantibody production is limited in nonautoimmune mice. J Immunol 169 (2002) 587-594
5. Hahn B.H., Ebling F., Singh R.R., Singh R.P., Karpouzas G., and L.A.C.A. Cellular and molecular mechanisms of regulation of autoantibody production in lupus. Ann N Y Acad Sci 1051 (2005) 433-441
6. Karpouzas G.A., La Cava A., Ebling F.M., Singh R.R., and Hahn B.H. Differences between CD8+ T cells in lupus-prone (NZB × NZW) F1 mice and healthy (BALB/c × NZW) F1 mice may influence autoimmunity in the lupus model. Eur J Immunol 34 (2004) 2489-2499
7. Tsokos G.C. Overview of cellular immune function in systemic lupus erythematosus. In: Lahita R.G. (Ed). Systemic Lupus Erythematosus (2004), Elsevier, Amsterdam 29-92
8. Stohl W. Impaired polyclonal T cell cytolytic activity. A possible risk factor for systemic lupus erythematosus. Arthritis Rheum 38 (1995) 506-516
9. Stohl W., Hamilton A.S., Deapen D.M., Mack T.M., and Horwitz D.A. Impaired cytotoxic T lymphocyte activity in systemic lupus erythematosus following in vitro polyclonal T cell stimulation: a contributory role for non-T cells. Lupus 8 (1999) 293-299
10. Stohl W., Elliott J.E., Li L., Podack E.R., Lynch D.H., and Jacob C.O. Impaired nonrestricted cytolytic activity in systemic lupus erythematosus: involvement of a pathway independent of Fas, tumor necrosis factor, and extracellular ATP that is associated with little detectable perforin. Arthritis Rheum 40 (1997) 1130-1137
11. de Saint Basile G., and Fischer A. The role of cytotoxicity in lymphocyte homeostasis. Curr Opin Immunol 13 (2001) 549-554
12. Kagi D., Odermatt B., and Mak T.W. Homeostatic regulation of CD8+ T cells by perforin. Eur J Immunol 29 (1999) 3262-3272
13. Cohen P.L., and Eisenberg R.A. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 9 (1991) 243-269
14. Peng S.L., Moslehi J., Robert M.E., and Craft J. Perforin protects against autoimmunity in lupus-prone mice. J Immunol 160 (1998) 652-660
15. Eisenberg R. The chronic graft-versus-host model of systemic autoimmunity. Curr Dir Autoimmun 6 (2003) 228-244
16. Kosmatopoulos K., Algara D.S., and Orbach-Arbouys S. Anti-receptor anti- MHC cytotoxic T lymphocytes: their role in the resistance to graft vs host reaction. J Immunol 138 (1987) 1038-1041
17. Via C.S., and Shearer G.M. Murine graft-versus-host disease as a model for the development of autoimmunity. Relevance of cytotoxic T lymphocytes. Ann N Y Acad Sci 532 (1988) 44-50
18. Sekiguchi D.R., Eisenberg R.A., and Weigert M. Secondary heavy chain rearrangement: a mechanism for generating anti-double-stranded DNA B cells. J Exp Med 197 (2003) 27-39
19. Sekiguchi D.R., Jainandunsing S.M., Fields M.L., Maldonado M.A., Madaio M.P., Erikson J., et al. Chronic graft-versus-host in Ig knockin transgenic mice abrogates B cell tolerance in anti-double-stranded DNA B cells. J Immunol 168 (2002) 4142-4153
20. Grader-Beck T., Casciola-Rosen L., Lang T.J., Puliaev R., Rosen A., and Via C.S. Apoptotic splenocytes drive the autoimmune response to poly(ADP-ribose) polymerase 1 in a murine model of lupus. J Immunol 178 (2007) 95-102
21. Gleichmann E., and Gleichmann H. Pathogenesis of graft-versus-host reactions (GVHR) and GVH-like diseases. J Invest Dermatol 85 (1985) 115s-120s
22. Gleichmann E., Van Elven E.H., and Van der Veen J.P. A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE. Eur J Immunol 12 (1982) 152-159
23. Treurniet R.A., Bergijk E.C., Baelde J.J., De Heer E., Hoedemaeker P.J., and Bruijn J.A. Gender-related influences on the development of chronic graft-versus-host disease-induced experimental lupus nephritis. Clin Exp Immunol 91 (1993) 442-448
24. Via C.S., Sharrow S.O., and Shearer G.M. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease. J Immunol 139 (1987) 1840-1849
25. Niculescu F., Niculescu T., Nguyen P., Puliaev R., Papadimitriou J.C., Gaspari A., et al. Both apoptosis and complement membrane attack complex deposition are major features of murine acute graft-vs.-host disease. Exp Mol Pathol 79 (2005) 136-145
26. Lang T.J., Nguyen P., Papadimitriou J.C., and Via C.S. Increased severity of murine lupus in female mice is due to enhanced expansion of pathogenic T cells. J Immunol 171 (2003) 5795-5801
27. Via C.S., Rus V., Gately M.K., and Finkelman F.D. IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease. J Immunol 153 (1994) 4040-4047
28. Lang T.J., Nguyen P., Peach R., Gause W.C., and Via C.S. In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function. J Immunol 168 (2002) 3786-3792
29. Via C.S., Shustov A., Rus V., Lang T., Nguyen P., and Finkelman F.D. In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL. J Immunol 167 (2001) 6821-6826
30. Via C.S., and Finkelman F.D. Critical role of interleukin-2 in the development of acute graft-versus-host disease. Int Immunol 5 (1993) 565-572
31. Shustov A., Luzina I., Nguyen P., Papadimitriou J.C., Handwerger B., Elkon K.B., et al. Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity. J Clin Invest 106 (2000) R39-47
32. Via C.S., Nguyen P., Shustov A., Drappa J., and Elkon K.B. A major role for the Fas pathway in acute graft-versus-host disease. J Immunol 157 (1996) 5387-5393
33. Shustov A., Nguyen P., Finkelman F., Elkon K.B., and Via C.S. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN- gamma production. J Immunol 161 (1998) 2848-2855
34. Rus V., Nguyen V., Puliaev R., Puliaeva I., Zernetkina V., Luzina I., et al. T cell TRAIL promotes murine lupus by sustaining effector CD4 Th cell numbers and by inhibiting CD8 CTL activity. J Immunol 178 (2007) 3962-3972
35. Thatayatikom A., and White A.J. Rituximab: a promising therapy in systemic lupus erythematosus. Autoimmun Rev 5 (2006) 18-24
36. Fan G.C., and Singh R.R. Vaccination with minigenes encoding V(H)-derived major histocompatibility complex class I-binding epitopes activates cytotoxic T cells that ablate autoantibody-producing B cells and inhibit lupus. J Exp Med 196 (2002) 731-741
37. Puliaev R., Puliaeva I., Krieg A., and Via C.S. Three different TLR9 CpG stimulants exhibit diverse effects in murine graft-versus host disease (GVHD). Clin Immunol (2005) Sup.:S8 (abst)
38. Puliaev R., Puliaeva I., Welniak L.A., Ryan A.E., Haas M., Murphy W.J., et al. CTL-promoting effects of CD40 stimulation outweigh B cell- stimulatory effects resulting in B cell elimination and disease improvement in a murine model of lupus. J Immunol 181 (2008) 47-61
39. Puliaeva I., Puliaev R., and Via C.S. Fas has both maturational and down regulatory roles in CD8+ cytotoxic T lymphocytes (CTL) in murine graft-vs-host disease (GVHD). J Immunol 176 (2006) S189
40. Puliaev R., Nguyen P., Finkelman F.D., and Via C.S. Differential requirement for IFN-gamma in CTL maturation in acute murine graft-versus-host disease. J Immunol 173 (2004) 910-919